Lincoln National Corp Qiagen N.V. Transaction History

Lincoln National Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$43.93 - $46.76 $226,986 - $241,608	-5,167 Reduced 32.34%	10,812 $486,000
Q1 2023 May 01, 2023	BUY	$45.29 - $50.76 $588 - $659	13 Added 0.08%	15,979 $733,000
Q4 2022 Feb 07, 2023	BUY	$41.91 - $50.48 $377 - $454	9 Added 0.06%	15,966 $796,000
Q3 2022 Nov 03, 2022	BUY	$40.9 - $50.42 $409 - $504	10 Added 0.06%	15,957 $658,000
Q1 2022 May 09, 2022	BUY	$42.23 - $54.3 $422 - $543	10 Added 0.06%	15,947 $781,000

Q3 2020 Nov 09, 2020	SELL	$42.51 - $52.42 $21,255 - $26,210	-500 Reduced 3.04%	15,937 $833,000
Q2 2020 Jul 31, 2020	BUY	$39.49 - $44.36 $19,745 - $22,180	500 Added 3.14%	16,437 $704,000
Q3 2019 Nov 06, 2019	BUY	$32.73 - $40.81 $3,142 - $3,917	96 Added 0.61%	15,937 $525,000
Q2 2019 Aug 06, 2019	SELL	$35.73 - $41.39 $30,727 - $35,595	-860 Reduced 5.15%	15,841 $642,000
Q1 2019 May 15, 2019	BUY	$33.78 - $40.68 $29,050 - $34,984	860 Added 5.43%	16,701 $679,000
Q1 2018 May 09, 2018	SELL	$31.01 - $34.72 $491,229 - $549,999	-15,841 Reduced 50.0%	15,841 $512,000
Q4 2017 Feb 13, 2018	BUY	$30.68 - $35.37 $486,001 - $560,296	15,841 Added 100.0%	31,682 $980,000
Q2 2017 Aug 07, 2017	BUY	N/A	15,841	15,841 $531,000

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.